{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:16:59Z","timestamp":1776442619893,"version":"3.51.2"},"reference-count":15,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,3,27]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Gastrointestinal stromal tumours (GISTs) are a rare subset of mesenchymal malignancy that may become diffusely metastatic and thereby present a unique range of perioperative challenges. We present the case of such a patient, a male in his 70s with metastatic GIST undergoing cytoreductive surgery. His perioperative course was notable for significant intraoperative blood loss secondary to persistent coagulopathy and refractory hypoglycaemia despite frequent monitoring paired with prompt intervention. These clinical complications were thought to be attributable to distinct characteristics of GIST, and our hope is to further contribute to the limited body of literature regarding the optimal anaesthetic care for these patients.<\/jats:p>","DOI":"10.1136\/bcr-2025-269750","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:35:11Z","timestamp":1776440111000},"page":"e269750","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative coagulopathy and refractory hypoglycaemia in a patient with metastatic gastrointestinal stromal tumour undergoing cytoreductive surgery"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4019-8143","authenticated-orcid":false,"given":"Bryce Alan","family":"Pierce","sequence":"first","affiliation":[{"name":"School of Medicine, Uniformed Services University, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Edgar","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel Brendon","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin C","family":"Cordova","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2026041708350513000_19.4.e269750.1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4251\/wjgo.v5.i6.102","article-title":"A gist of gastrointestinal stromal tumors: A review","volume":"5","author":"Rammohan","year":"2013","journal-title":"World J Gastrointest Oncol"},{"key":"2026041708350513000_19.4.e269750.2","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-7-61","article-title":"Gastrointestinal stromal tumor","volume":"7","author":"Stamatakos","year":"2009","journal-title":"World J Surg Oncol"},{"key":"2026041708350513000_19.4.e269750.3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOG.0b013e32802086d0","article-title":"Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease","volume":"23","author":"Raut","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"2026041708350513000_19.4.e269750.4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41571-022-00606-4","article-title":"New treatment strategies for advanced-stage gastrointestinal stromal tumours","volume":"19","author":"Klug","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026041708350513000_19.4.e269750.5","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165(2006)130[1466:GSTROM]2.0.CO;2"},{"key":"2026041708350513000_19.4.e269750.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.9705"},{"key":"2026041708350513000_19.4.e269750.7","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.3748\/wjg.v27.i41.7125","article-title":"Current update on molecular cytogenetics, diagnosis and management of gastrointestinal stromal tumors","volume":"27","author":"Wang","year":"2021","journal-title":"World J Gastroenterol"},{"key":"2026041708350513000_19.4.e269750.8","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2024.14701","article-title":"Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia","volume":"28","author":"Chida","year":"2024","journal-title":"Oncol Lett"},{"key":"2026041708350513000_19.4.e269750.9","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0397","article-title":"Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib","volume":"155","author":"Gronchi","year":"2020","journal-title":"JAMA Surg"},{"key":"2026041708350513000_19.4.e269750.10","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231192388","article-title":"2023 GEIS Guidelines for gastrointestinal stromal tumors","volume":"15","author":"Serrano","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"2026041708350513000_19.4.e269750.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70299-6"},{"key":"2026041708350513000_19.4.e269750.12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00384-022-04214-7","article-title":"Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis","volume":"37","author":"Jiang","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"2026041708350513000_19.4.e269750.13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3892\/ol.2012.779","article-title":"Treatment of a GIST patient with modified dose of sunitinib by measurement of plasma drug concentrations","volume":"4","author":"Hashita","year":"2012","journal-title":"Oncol Lett"},{"key":"2026041708350513000_19.4.e269750.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3525"},{"key":"2026041708350513000_19.4.e269750.15","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.471","article-title":"A systematic review of literature on Insulin-like growth factor-2-mediated hypoglycaemia in non-islet cell tumours","volume":"7","author":"Ata","year":"2024","journal-title":"Endocrinol Diabetes Metab"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-269750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:35:13Z","timestamp":1776440113000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-269750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bcr-2025-269750"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-269750","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}